Daniel has provided holistic, pragmatic counsel to tech companies at all stages of the life cycle, from start-up to Fortune 500. He has advised emerging tech companies (with a focus on health tech and AI) and traditional life sciences companies (pharma, biotech, med device) on complex commercial and intellectual property (IP)-focused transactions, development pipeline agreements, capital raises, M&A, IP portfolio strategy and litigation, and internal governance. Daniel was outside counsel to Dyania Health at Orrick before joining the team full-time. He studied Neuroscience and Business at USC, obtained a MS in Biotechnology from Johns Hopkins, and has his law degree from Southwestern Law School. Daniel is also a registered patent attorney.